News for Eiger BioPharmaceuticals Stock (EIGR)

RM LAW Announces Class Action Lawsuit Against Eiger Biopharmaceuticals, Inc.

PRNewsWire • 12/19/22

ROSEN, A TOP RANKED LAW FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - EIGR

PRNewsWire • 12/16/22

Eiger BioPharmaceuticals Announces Leadership Change

Business Wire • 12/15/22

ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EIGR

Business Wire • 12/12/22

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

Accesswire • 12/12/22

EIGR INVESTOR NEWS: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EIGR

PRNewsWire • 12/10/22

Eiger BioPharmaceuticals to Host Conference Call to Discuss Phase 3 D-LIVR Study Results of Lonafarnib-based Treatments in Hepatitis Delta Virus (HDV) on Thursday, December 8, 2022

PRNewsWire • 12/07/22

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - EIGR

Newsfile Corp • 12/06/22

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EIGR

PRNewsWire • 12/03/22

ROSEN, A TOP RANKED FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - EIGR

Newsfile Corp • 11/28/22

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eiger BioPharmaceuticals, Inc. (EIGR)

Business Wire • 11/28/22

Eiger BioPharmaceuticals: A Compelling High Beta Story

Seeking Alpha • 11/26/22

ROSEN, A LEADING NATIONAL FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EIGR

Newsfile Corp • 11/25/22

SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Class Action Lawsuit Against Eiger BioPharmaceuticals, Inc. (EIGR) Encourages Long-Term EIGR Investors to Contact the Firm

Newsfile Corp • 11/25/22

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - EIGR

PRNewsWire • 11/24/22

ROSEN, Leading Investor Counsel, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - EIGR

Newsfile Corp • 11/20/22

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Eiger BioPharmaceuticals, Inc. (EIGR) Investors

Business Wire • 11/18/22

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Eiger BioPharmaceuticals, Inc. (EIGR) Investors

Business Wire • 11/17/22

EIGER BIOPHARMACEUTICALS CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Eiger BioPharmaceuti

PRNewsWire • 11/17/22

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EIGR

PRNewsWire • 11/17/22

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Eiger BioPharmaceuticals, Inc. (EIGR) on Behalf of Investors

Business Wire • 11/16/22

Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Notifies Eiger BioPharmaceuticals, Inc. (EIGR) Investors of Class Action and Encourages Investors to Actively Participate

Business Wire • 11/16/22

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Eiger BioPharmaceuticals, Inc. (EIGR) on Behalf of Investors

Business Wire • 11/16/22

The Law Offices of Frank R. Cruz Announces Investigation of Eiger BioPharmaceuticals, Inc. (EIGR) on Behalf of Investors

Business Wire • 11/15/22

EIGER ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Eiger Biopharmaceuticals, Inc. and Encourages Investors to Contact the Firm

Business Wire • 11/15/22